LETKO, BROSSEAU & ASSOCIATES INC Q2 2024 Filing

Filed August 6, 2024

Portfolio Value

$5.3B

Holdings

104

Report Date

Q2 2024

Filing Type

13F-HR

All Holdings (104 positions)

#StockSharesValue% PortfolioType
101
OMGBPOUTSET MED INC
13,550$52.2M0.99%
102
PROKPROKIDNEY CORP
15,900$39.1M0.74%
103
GLYCEURGLYCOMIMETICS INC
45,250$12.7M0.24%
104
LYRALYRA THERAPEUTICS INC
31,900$8.8M0.17%
PreviousPage 2 of 2